Skip to main content
Cytogen, Inc. logo

Cytogen, Inc. — Investor Relations & Filings

Ticker · 217330 ISIN · KR7217330000 KO Manufacturing
Open in API
Filings indexed 437 across all filing types
Latest filing 2024-02-29 Board/Management Inform…
Country KR South Korea
Listing KO 217330

About Cytogen, Inc.

https://www.cytogenlab.com/

Cytogen, Inc. is a biotechnology company specializing in liquid biopsy platforms for precision oncology. The company has developed proprietary technology for the rapid isolation and analysis of viable Circulating Tumor Cells (CTCs) from whole blood. Its core offering, the SmartBiopsy Platform, utilizes a high-density microporous chip with microfluidics and nanotechnology to capture CTCs efficiently. This non-invasive diagnostic approach is designed to support early cancer detection, treatment monitoring, and the advancement of personalized medicine for cancer patients.

Recent filings

Filing Released Lang Actions
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's leadership, specifically the appointment of a new co-CEO (각자대표). It details the change in representatives, the reason for the change, the date of the board resolution, and the professional background of the new appointee. This aligns perfectly with the definition for Board/Management Information (MANG).
2024-02-29 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (EGM) for the company 'Cytogen'. It lists the agenda items (appointment of directors) and the outcome of the votes (approved as proposed). This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2024-02-21 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment or resignation of an outside director (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). This falls under the category of board or management changes, which is classified as MANG.
2024-02-21 Korean
전환사채(해외전환사채포함)발행후만기전사채취득 (제4회차)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) regarding the acquisition of convertible bonds before maturity (Put option exercise). This falls under capital structure changes and financing updates. Since it specifically details the acquisition of debt instruments (convertible bonds) by the issuer, it is classified as a Capital/Financing Update (CAP).
2024-02-20 Korean
전환가액의조정 (제4회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the adjustment of the conversion price for convertible bonds (제4회차). This type of disclosure, which details changes to capital structure instruments like convertible bonds, falls under the 'Capital/Financing Update' category as it directly relates to the company's financing activities and capital structure adjustments.
2024-02-20 Korean
[기재정정]타법인주식및출자증권취득결정(자율공시)
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from the Korean company CytoGen regarding an amendment to a previous disclosure about the acquisition of shares in another corporation (CytoGen Japan). It details the change in the expected acquisition date due to administrative scheduling. Since this is a specific regulatory announcement regarding corporate investment activity that does not fit into categories like M&A (which usually implies larger scale mergers/takeovers) or capital changes, it falls under the general regulatory filing category.
2024-02-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.